A genetic variation of SOD2 does not determine duration of response to androgen deprivation therapy for prostate cancer

BACKGROUND: Silencing SOD2 expression up-regulates AR signaling and expression of SOD2 is down-regulated in CRPC, compared with untreated tumors. The decreased SOD2 activity could lead to AR gain-of-function and the development of castration-resistance. METHOD: We genotyped SOD2-rs4880 in a cohort o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Xie, Wanling, Drouin, Sarah, Nakabayashi, Mari, Pomerantz, Mark, Lee, Gwo-Shu Mary, Kantoff, Philip W., Sharifi, Nima
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5637518/
https://ncbi.nlm.nih.gov/pubmed/27325180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados